Last edition
News about "CDSCO"
Health Ministry Notifies Stricter Drug Rules against Fake Data
Union Health Ministry notifies stricter Drugs Rules, empowering licensing authorities to debar applicants submitting fake or fabricated data.
CDSCO | 07/08/2026 | By News Bureau
India to Build Future-Ready Drug Regulatory Framework: J P Nadda
India will build a future-ready drug regulatory framework, with the Central Drugs Standard Control Organisation (CDSCO) set to launch an end-to-end digital regulatory platform within 18 months.
CDSCO | 01/08/2026 | By News Bureau
The Central Drugs Standard Control Organisation (CDSCO) has clarified the regulatory framework for formulation intermediates, specifying which products require central approval under the NDCT Rules, 2019 and which can be licensed by State Licensing Authorities (SLAs).
CDSCO | 25/06/2026 | By News Bureau | 123
Indian Pharmacopoeia Commission (IPC) hosts the Indian Pharmacopoeia (IP) 2026 Scientific Conclave and Interactive Session, focusing on medicine quality, impurity standards, regulatory science, and patient safety.
CDSCO | 16/05/2026 | By News Bureau | 151
CDSCO Cracks Down on Unlicensed IVF Medical Devices
The Central Drugs Standard Control Organisation (CDSCO) has directed its zonal and sub-zonal offices, along with State Licensing Authorities (SLAs), to maintain strict vigilance against the sale of unlicensed medical devices used in In Vitro Fertilisation (IVF) and Assisted Reproductive Technology (ART) procedures.
CDSCO | 30/03/2026 | By Darshana | 208
CDSCO Approves AstraZeneca Pharma India's Durvalumab for uHCC Treatment
AstraZeneca Pharma India has received CDSCO approval for durvalumab to treat unresectable hepatocellular carcinoma (uHCC), a major global health concern as HCC ranks among the most common and deadliest cancers worldwide.
CDSCO | 18/03/2026 | By Akanki | 148
ACC Extends Dr Rajeev Singh Raghuvanshi's appointment as Drugs Controller (India) for One Year
Dr Rajeev Singh Raghuvanshi receives a second one-year extension as head of CDSCO amid ongoing regulatory reforms and Schedule M implementation.
CDSCO | 02/03/2026 | By News Bureau | 961
CDSCO to Outsource GMP Audits and Add 1,500 Experts to Boost Scientific Oversight
Central Drugs Standard Control Organisation has announced plans to strengthen its regulatory framework by outsourcing Good Manufacturing Practice (GMP) audits to accredited third-party agencies and expanding its scientific workforce by approximately 1,500 experts.
CDSCO | 24/02/2026 | By Darshana | 328
CDSCO Flags 240 Drug Samples as Not of Standard Quality in January 2026
Central Drugs Standard Control Organisation has reported that 240 drug samples tested across India in January 2026 were found to be Not of Standard Quality (NSQ). Of these, 68 samples were identified by Central Drugs Laboratories, while 172 were flagged by State Drugs Testing Laboratories.
CDSCO | 23/02/2026 | By Darshana | 1995
Union Budget Boosts Pharma with Biopharma Shakti with Outlay of INR 10,000 Crore
Union Finance Minister Nirmala Sitharaman unveiled multiple initiatives for pharma and life sciences in budget 2026–27, including Biopharma Shakti, NIPER expansion, CDSCO strengthening and new investments, to position India as a global biopharma hub.
CDSCO | 01/02/2026 | By News Bureau | 315
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy